Welcome to the ValueWiki Anadys Pharmaceuticals, Inc. (ANDS) article! Register for free or click the "edit" link to contribute!

Anadys Pharmaceuticals, Inc. (ANDS)

This summary section needs content! Click Here to begin writing.

Have a question about Anadys Pharmaceuticals, Inc.? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

12/02/08 2:12 pm	Movers roundup: Isle of Capri, Anadys Pharma (AP)
12/02/08 12:12 pm	Anadys shares rise on review for hepatitis C drug (AP)
12/02/08 7:12 am	InPlay: Anadys Pharma announces ANA598 receives fast track designation from the FDA for the Treatment of Chronic Hepatitis C infection (Briefing.com)
12/01/08 6:12 pm	ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection (PR Newswire)
11/25/08 6:11 pm	Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference (PR Newswire)
11/24/08 10:11 am	Coverage initiated on Anadys Pharma by Noble Financial (Briefing.com)
11/13/08 5:11 pm	Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference (PR Newswire)
11/04/08 4:11 pm	Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference (PR Newswire)
11/01/08 9:11 am	Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers (PR Newswire)
10/30/08 3:10 pm	Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients (PR Newswire)